GlassScriptPhysician profile
Kenneth G Ney
NPI 1841204542
$54,507.57
in general payments reported to CMS, 2019-2025
59 companies · $2,194 in 2025
The $2,194 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $6,461 · 2020: $1,505 · 2021: $15K · 2022: $12K · 2023: $11K · 2024: $6,714 · 2025: $2,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $7,377 · Travel and Lodging: $710 · Education: $97.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,317.50 |
| Food and Beverage | $7,377.11 |
| Travel and Lodging | $709.77 |
| Education | $97.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $32,514.88 | 2019-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $11,085.27 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $1,112.75 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $997.96 | 2019-2025 | |
| Boston Scientific Corporation | $809.84 | 2019-2024 | Rezum Generator, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $794.53 | 2019-2025 | Xtandi, Myrbetriq |
| Genzyme Corporation | $584.86 | 2019-2023 | |
| Accord Healthcare, INC. | $523.57 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $432.81 | 2019-2024 | Xiaflex, Aveed |
| Pfizer INC. | $386.31 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $348.45 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Progenics Pharmaceuticals, INC. | $328.94 | 2022-2025 | Pylarify |
| Amgen INC. | $321.68 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $294.86 | 2019-2024 | Yonsa |
| Endo USA, INC. | $281.09 | 2024-2025 | Xiaflex, Aveed |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $274.73 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $268.52 | 2019-2025 | Lynparza |
| Myriad Genetic Laboratories, INC. | $245.32 | 2021-2025 | Prolaris |
| Abbvie INC. | $243.08 | 2019-2025 | |
| Blue Earth Diagnostics | $224.80 | 2019-2024 | |
| C. R. Bard, INC. & Subsidiaries | $224.45 | 2024-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Tolmar Pharmaceuticals, INC. | $205.90 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $204.30 | 2019-2025 | |
| Becton, Dickinson and Company | $169.06 | 2024 | Bard Urinary Drainage Bag |
| Rochester Medical Corporation | $145.53 | 2021-2022 | |
| Urogen Pharma, INC. | $136.51 | 2022-2025 | |
| Antares Pharma, INC. | $134.09 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Intuitive Surgical, INC. | $99.13 | 2019 | |
| Tolmar, INC. | $82.83 | 2023-2025 | Jatenzo, Eligard |
| Tempus Ai, INC | $80.01 | 2024 | |
| Clovis Oncology, INC. | $68.56 | 2020 | |
| Coloplast Corp | $66.87 | 2022-2024 | |
| Calyxo, INC. | $65.42 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $62.92 | 2022-2023 | Axonics |
| Medtronic, INC. | $57.50 | 2023-2025 | Interstim |
| Laborie Medical Technologies Corp. | $49.30 | 2020-2025 | |
| Dentsply Ih Ab | $47.61 | 2024-2025 | Lofric |
| Ferring Pharmaceuticals INC. | $47.50 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $44.70 | 2019-2020 | |
| Procept Biorobotics Corporation | $38.53 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Palette Life Sciences, INC. | $37.35 | 2022 | |
| Teleflex LLC | $32.60 | 2024-2025 | Barrigel, Urolift |
| Olympus America INC. | $32.21 | 2025 | Itind System |
| Telix Pharmaceuticals | $28.27 | 2023 | Illuccix |
| Vertex Pharmaceuticals Incorporated | $24.55 | 2024 | |
| Hollister Incorporated | $23.46 | 2023 | Vapro Plus Pocket, Infyna Chic |
| Travere Therapeutics, INC. | $22.43 | 2020 | |
| Ethicon US, LLC | $21.56 | 2019 | |
| Janssen Scientific Affairs, LLC | $19.12 | 2021 | |
| Bioprotect Medical, INC. | $19.11 | 2025 | Bioprotect Balloon Implant System |
| Urovant Sciences INC | $18.97 | 2022 | |
| Edap Technomed INC | $18.88 | 2025 | |
| Zyla Life Sciences, INC. | $18.31 | 2019 | |
| Koelis INC. | $17.32 | 2023 | |
| Halozyme INC | $16.06 | 2023 | |
| Cook Medical LLC | $15.74 | 2023 | Cook |
| Immunitybio, INC. | $14.03 | 2025 | |
| Allergan, INC. | $11.34 | 2020 | |
| Foundation Medicine, INC. | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$8,777.98 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Ney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.